🔗 Share this article

This year's prestigious award in Physiology or Medicine has been granted for revolutionary discoveries that clarify how the body's defense network targets dangerous pathogens while sparing the body's own cells.

Three esteemed scientists—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this honor.

Their research uncovered specialized "security guards" within the defense system that remove malfunctioning defense cells capable of harming the organism.

The findings are now enabling new therapies for autoimmune diseases and malignancies.

These laureates will divide a monetary award worth 11m SEK.

Crucial Findings

"Their work has been decisive for comprehending how the immune system operates and why we do not all suffer from serious self-attack conditions," commented the head of the award panel.

The team's studies address a core question: In what way does the immune system defend us from countless infections while keeping our own tissues unharmed?

The immune system employs white blood cells that search for indicators of infection, including pathogens and bacteria it has never encountered.

These cells utilize sensors—called recognition units—that are generated by chance in a vast number of combinations.

That gives the defense network the capacity to fight a wide array of threats, but the randomness of the mechanism unavoidably produces immune cells that may target the body.

Security Guards of the Immune System

Researchers previously understood that some of these harmful white blood cells were destroyed in the immune organ—the site where white blood cells mature.

This year's Nobel Prize honors the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the body to neutralize other immune cells that assault the healthy cells.

It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.

A prize committee stated, "These discoveries have established a new field of investigation and spurred the creation of new therapies, for instance for tumors and immune disorders."

Regarding cancer, regulatory T-cells prevent the body from fighting the tumor, so studies are focused on lowering their numbers.

For self-attack disorders, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A similar method could also be useful in reducing the risks of transplanted organ failure.

Innovative Experiments

Professor Shimon Sakaguchi, of Osaka University, conducted tests on mice that had their immune gland removed, leading to self-attack conditions.

The researcher showed that injecting immune cells from healthy mice could prevent the disease—implying there was a mechanism for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and humans that resulted in the discovery of a genetic factor vital for how T-regs operate.

"Their groundbreaking research has uncovered how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the body's own tissues," commented a prominent biological science expert.

"The research is a striking illustration of how basic physiological study can have far-reaching consequences for human health."